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Abstract
The aim of this study was to develop a three-dimensional (3D) model of the
human blood-brain barrier , which mimics the cellular architecture of thein vitro
CNS and could be used to analyse the delivery of nanoparticles to cells of the
CNS. The model includes human astrocytes set in a collagen gel, which is
overlaid by a monolayer of human brain endothelium (hCMEC/D3 cell line). The
model was characterised by transmission electron microscopy (TEM),
immunofluorescence microscopy and flow cytometry. A collagenase digestion
method could recover the two cell types separately at 92-96% purity. 
Astrocytes grown in the gel matrix do not divide and they have reduced
expression of aquaporin-4 and the endothelin receptor, type B compared to
two-dimensional cultures, but maintain their expression of glial fibrillary acidic
protein. The effects of conditioned media from these astrocytes on the barrier
phenotype of the endothelium was compared with media from astrocytes grown
conventionally on a two-dimensional (2D) substratum. Both induce the
expression of tight junction proteins zonula occludens-1 and claudin-5 in
hCMEC/D3 cells, but there was no difference between the induced expression
levels by the two media. The model has been used to assess the transport of
glucose-coated 4nm gold nanoparticles and for leukocyte migration. TEM was
used to trace and quantitate the movement of the nanoparticles across the
endothelium and into the astrocytes. This blood-brain barrier model is very
suitable for assessing delivery of nanoparticles and larger biomolecules to cells
of the CNS, following transport across the endothelium.
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Introduction
The human blood brain barrier presents a major challenge for the 
pharmaceutical industry, and a number of cell culture systems 
have been developed which model different aspects of the barrier 
(Naik & Cucullo, 2012; Ogunshola, 2011). In vivo, the barrier is 
formed by specialised brain endothelial cells that have continuous 
tight junctions, low pinocytotic activity and a set of enzymes and 
ABC-transporters that metabolise or exclude many xenobiotics 
(Sarkadi et al., 2006; Wolburg & Lippoldt, 2002). The function and 
structure of the brain endothelium is supported by astrocytes; astro-
cytic foot processes ensheath the abluminal side of the endothe-
lium and form a double basal lamina, with the endothelium (Abbott 
et al., 2010). Several tissue culture models of the barrier have been 
developed and each one has some of the characteristics seen in vivo, 
although the barrier is generally not as tight as in vivo (Butt et al., 
1990). Hence, each model is suitable for specific purposes, although 
none of the models is ideal for all applications (Naik & Cucullo, 
2012). One aim of this study was to develop a model of the human 
blood-brain barrier, which could be used to study nanoparticle 
movement across brain endothelium and localisation in glial cells. 
This model might also be used to study interactions between brain 
endothelium and astrocytes.
One problem in the development of barrier models is the limited 
availability of primary human brain endothelium, although this has 
been partly compensated by the development of stem-cell derived 
brain endothelium (Lippmann et al., 2012). Primary endothelium 
at low passage has high resistance tight junctions, and expresses 
appropriate transporters, but the barrier phenotype tends to decline 
in extended culture (Lyck et al., 2009). The availability of the 
human brain endothelial line hCMEC/D3 (Weksler et al., 2005) has 
been used to develop several in vitro models (Weksler et al., 2013). 
These cells do not form a strong barrier for molecules <4kDa under 
static conditions, although the transendothelial electrical resist-
ance (TEER) is enhanced in flow-based conditions (Cucullo et al., 
2008).
Barrier models which include human astrocytes have generally cul-
tured the endothelium on the upper surface of filters in transwell 
inserts, and the astrocytes are either cultured on the lower surface 
of the filter or on the base of the culture well (Naik & Cucullo, 
2012). As the pore area is generally <20% of the filter area and 
with a filter being 10–30μm thick, there is little opportunity for con-
tact between the astrocytes and the endothelium as occurs in vivo. 
Moreover, growing astrocytes on a two-dimensional surface (2D-
astrocytes) can affect their phenotype (Maltman & Przyborski, 
2010). Recently collagen gels containing different cell types have 
been used to model the three-dimensional (3D) environment found 
in tissues in vivo (Lee et al., 2008). Rat astrocytes cultured in 3D 
matrices are less reactive than 2D-astrocytes (East et al., 2009). They 
have a different morphology, slower growth rate and fewer stress 
fibres. 2D-astrocytes spontaneously become reactive (Holley et al., 
2005; Wu & Schwartz, 1998) and may secrete inflammatory 
cytokines and angiogenic factors, which interfere with the main-
tenance of the endothelial barrier. In addition, astrocytes grown on 
rigid 2D surfaces are subject to different positional cues to cells 
in a 3D matrix. For these reasons, 2D-astrocytes do not reflect the 
phenotype of astrocytes in vivo. In the model developed here, 
human astrocytes were cultured in a 3D collagen hydrogel, overlaid 
with a human brain endothelial cell line forming a monolayer on the 
gel surface. The arrangement allows contact between the endothe-
lium and astrocytes and free movement of larger biomolecules and 
nanoparticles between the basal surface of the endothelium and the 
astrocytes in the underlying gel.
Materials and Methods
Endothelial and astrocyte cultures
Human foetal cortical astrocytes at passage 1, were obtained from 
ScienCell Research Laboratories (Carlsbad, CA, USA) and were 
maintained on collagen type-I coated tissue culture dishes in human 
astrocyte medium (ScienCell Research Laboratories, Carlsbad, CA, 
USA) including 2% foetal bovine serum and the recommended 
growth supplements as per the manufacturer. Analysis of these cul-
tures by immunofluorescence indicated that 29.2–46.9% of cells 
were GFAP+ at the start of the cultures and approximately 90% of 
the cells were S100β+, indicating that the majority of cells were 
astrocytes. Fibroblasts (TE7+) constituted 1.7–2.8% of the cells at 
passages 2–4. Oligodendrocytes (O1+) and microglia (CD68+) were 
not detectable in the astrocyte cultures.
The human cerebral microvascular endothelial cell line hCMEC/D3 
(Weksler et al., 2005) at passage 24–30 was cultured on collagen-
coated flasks or tissue culture inserts in EBM-2 medium (Lonza, 
Basel, Switzerland) supplemented with 2.5% foetal bovine serum, 
hydrocortisone, VEGF, epidermal growth factor (EGF), insulin- like 
growth factor I (IGF-I), human fibroblast growth factor (FGF), ascor-
bic acid and gentamicin sulphate according to the manufacturer’s 
formulation. All cells were cultured at 37°C in 100% humid air 
containing 5% CO2, unless otherwise indicated. The medium was 
changed every 2–3 days.
3D-astrocyte cultures and 3D-astrocyte-endothelial 
co-cultures
Collagen gels containing 0.5 × 106 astrocytes per ml were prepared 
in 24-well plates, with an initial volume of 450μl cellular colla-
gen gel per well. Gels were composed of a 10% cell suspension of 
human astrocytes, passage 2–4, in DMEM (Gibco, Thermo Fisher 
Scientific, UK), 10% 10× minimum essential medium (MEM; 
Sigma, UK) and 80% type I rat tail collagen (2.5 mg/ml; First Link, 
Wolverhampton, UK). The collagen was diluted from a 5mg/ml 
0.6% acetic acid stock using water, then mixed with MEM and neu-
tralised using sodium hydroxide (assessed by colour change of the 
phenol red indicator to orange-red), then the mixture was added to 
the cell suspension and mixed to ensure even distribution of cells 
before transferring to the 24-well plates or transwell inserts. Gela-
tion took approximately 10 min at 37°C and then astrocyte medium 
was added. In preliminary experiments the astrocyte density was 
varied between 0.25 × 106 astrocytes/ml and 2.0 × 106 astrocytes/ml. 
At higher densities the astrocytes caused the gel matrix to contract 
and detach from the sides of the wells. Therefore, the optimal den-
sity for astrocytes was established as 0.5 × 106 astrocytes/ml for 
cultures of ≤7 days. If the gels were compressed (see below), or for 
shorter duration cultures, cell densities up to 1.5 × 106 astrocytes/ml 
could be used.
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For astrocyte/endothelial co-cultures, astrocyte-containing gels were 
established as described above, either in 24-well plates or 1cm 
inserts, containing 0.5 × 106 astrocytes per ml (uncompressed gel) 
or 1.2 × 106 astrocytes per ml (compressed gel). After gelation astro-
cytes were cultured for 2h in astrocyte medium. Some of the gels 
were then stabilised (compressed) using RAFT™ absorbers (TAP 
Biosystems, Royston, UK – now available from Lonza, UK) for 
15 min to remove fluid and reduce gels to less than 10% of their orig-
inal volume. Uncompressed gels were 1–2mm thick: compressed 
gels were <0.1mm thick. The gels were maintained for a further 24h 
in astrocyte medium before being overlaid with hCMEC/D3 cells 
at a density of 60,000 cells/cm2. The co-cultures were incubated at 
37°C for 3 days in EGM2-MV medium, before characterisation or 
use in transcytosis experiments.
Immunofluorescence in situ 
The details of antibodies used for immunofluorescence and flow 
cytometry are given in Table 1. 3D cultures were stained by simi-
lar methods to conventional 2D cultures, except that the wash 
times were extended. The gels were rinsed with Hank’s balanced 
salt solution (HBSS) without Ca++/Mg++, fixed in 4% fresh para-
formaldehyde in phosphate buffered saline (PBS) for 45 min and 
washed for 30 min in three changes of PBS. The gels were then 
detached from the wells, incubated with 0.05% w/v saponin in PBS 
and 5% normal goat serum for 1h and washed 3× in PBS before 
incubation overnight in primary antibody. Gels were washed for 1h 
with 4 changes of PBS before incubation with secondary antibod-
ies and 1μg/ml Hoechst 33259 for 90 min. Secondary antibodies 
were 10μg/ml Alexafluor-488 or -555 conjugated goat antibodies 
Table 1. Antibodies.
Antibody* Usage Conc. Supplier
Aquaporin-4 
   Rabbit Primary, indirect IF 2μg/ml
Santa Cruz 
Biotechnology Inc. 
#sc-20812
Claudin-5 
   Mouse IgG Primary, indirect IF 2.5μg/ml
Invitrogen Ltd 
#35-2500
EDNRB 
   Rabbit Primary, indirect IF 8μg/ml
Alomone labs 
#AER-002
ZO-1 
   Rabbit Primary, indirect IF 2.5μg/ml
Zymed 
#61-7300
P-gp 
   Mouse IgG Primary, indirect IF 5μg/ml
Kamiya Biomedical Co.  
#MC012
GFAP 
   Mouse IgG Primary, indirect IF 2.4μg/ml
Sigma Aldrich Inc. 
# G3893
S100β 
   Rabbit Primary, indirect IF 1/200
Abcam 
#ab52642
TE7 
   Mouse IgG Primary, indirect IF 0.67μg/ml
Millipore (UK) Ltd 
#CBL271
O1 
   Mouse IgM Primary, indirect IF 1μg/ml
R&D systems 
#MAB1327
CD68 
    Mouse IgG Primary, indirect IF 2μg/ml
Dako (UK) Ltd 
#F7135
PECAM1 
   Mouse IgG Primary, indirect IF 10μg/ml
R&D systems 
#BBA7
PECAM1-PerCP-
eFluor710 Direct IF 1.25μg/ml
eBioscience Ltd 
#46-0319-42
Anti-mouse-IgG-
AlexaFluor 488 Secondary, indirect IF 10μg/ml
Invitrogen Ltd 
#A11001
Anti-mouse-IgG-
AlexaFluor 555 Secondary, Indirect IF 10μg/ml
Invitrogen Ltd  
#A21422
Anti-mouse-IgM Secondary, Indirect IF 5μg/ml AbD Serotec  #MCA199F
Anti-rabbit-IgG 
AlexaFluor 488 Secondary Indirect IF 10μg/ml
Invitrogen Ltd  
#A11008
* All mouse primary antibodies are monoclonal. All others are polyclonal.
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to mouse or rabbit IgG (Invitrogen Ltd). Finally the gels were 
washed for 6h with 12 changes of PBS and imaged using a Leica 
TCS SP5 confocal microscope (Leica, Germany). From the z-stack 
of images, a maximal intensity projection image was generated. In 
the case of 2D cultures, for comparison of treatments, ten images 
were captured in randomly selected fields using an Olympus BX61 
microscope. Fluorescence intensity was analysed using ImagePro 
software (MediaCybernetics UK, v8) and the percentage of pixels 
exceeding a threshold pixel-density was measured. The threshold 
value was set according to the background intensity and this value 
was constant across all images in each experiment. For analysis of 
zonula occludens-1 (ZO-1), nuclear and perinuclear staining was 
excluded from the analysis whereas for claudin-5 (CLDN5), the 
intensity across the whole cell was measured. In each experiment, 
the results were normalised to the reference treatment, by dividing 
the stained area of treated cells by the stained area of control cells. 
The normalised values from different experiments were then com-
bined to give mean fluorescence intensity ±SEM.
Cell recovery and flow cytometry
To recover cells, the gels were subjected to collagenase digestion. 
3D gel cultures of astrocytes were rinsed with HBSS and incubated 
for 45 min at 37°C with 0.25% collagenase, 10μg/ml DNAse I and 
0.147μg/ml TLCK hydrochloride (Tosyl-Lys-chloromethylketone.
HCl) in DMEM. Digestion was terminated by addition of 20mM 
EDTA, and cells recovered by centrifugation at 320g for 5 min. To 
isolate hCMEC/D3 cells from co-cultures a two-step collagenase 
digestion was developed. The gels were first treated as above for 
15 min and the hCMEC/D3 monolayer detached from the gel 
surface intact and placed in 0.25% trypsin-EDTA to dissociate the 
cells (step-1). The collagenase digestion of the gel was continued 
for a further 30 min in order to recover the astrocytes (step-2).
The two-step collagenase digest for recovering cell populations 
was validated by measuring the purity of the astrocyte fraction after 
co-culture. Endothelial cells (hCMEC/D3) were pre-labelled with a 
fluorescent tracker, 5-chloromethylfluorescein diacetate (CMFDA), 
and cultured with the astrocytes for 7 days. The endothelial mon-
olayer was removed and the astrocytes recovered and analysed 
by flow cytometry (see below). The level of contamination of the 
astrocytes by endothelium, measured by PECAM-1 staining 
(endothelial marker) was in the range 5–8%, in different experi-
ments (n=3). Median fluorescence of astrocytes in monoculture in 
these FACS conditions was 4.7 units, and that of astrocytes isolated 
from co-cultures was 5.0 units. Isolated endothelium had a median 
fluorescence of 187 units.
Isolated populations of endothelium or astrocytes were character-
ised by flow cytometry. Endothelium was labelled with monoclonal 
antibody to PECAM-1, directly conjugated to PerCP-eFluor-710 
for 30 min at 4°C in diluent containing 0.1% NaN3 and 0.1% BSA 
in PBS. For indirect immunofluorescence, cells were trypsinised, 
washed and fixed in 4% paraformaldehyde. After two washes, cells 
were incubated with primary antibodies for 1h at room temperature 
in PBS containing 0.1% BSA and 2.5% normal goat serum. Con-
trol staining was carried out simultaneously with a corresponding 
matched isotype IgG for mouse primary antibodies, or antibody 
diluent for rabbit antibodies. Each wash was done in 4ml of PBS; 
cells were collected by centrifuging at 320g for 5 min. If cell- 
permeabilization was needed (for primary antibodies recognis-
ing intracellular epitopes), saponin (0.05%, final concentration) 
was added to the antibody diluent and washing buffer. After incu-
bation with primary antibody, the cells were washed twice, then 
incubated with 10 μg/ml of Alexa Fluor® 488 conjugated second-
ary antibodies for 45 min. Cells were washed twice, suspended in 
PBS, then analysed by FACSCalibur™ using Cell Quest software 
(Becton Dickinson, UK). For each sample, data from 10,000 cells 
were collected. Each determination was performed with 3 or 4 rep-
licates and the data is expressed as the mean (±SEM) of the median 
fluorescence from each replicate. Experiments compared different 
conditions using paired t-tests.
Transmission electron microscopy (TEM)
3D co-culture gels prepared on transwell inserts were washed 3× 
in PBS and fixed in 2.5% glutaraldehyde in Sörensons phosphate 
buffer (PB) for 1 hour. Post-fixation was carried out with 1% (w/v) 
osmium tetroxide in 0.1M PB for 1 hour and the inserts were then 
washed in 0.1M PB for 10 min. The filters were excised from the 
insert and randomly cut into 2 segments of 3–5mm × 2mm. These 
segments were progressively dehydrated in a graded series of etha-
nol from 30% to 100%, embedded in Epon resin (Agar Scientific, 
UK) and polymerised at 60°C for 48h. Ultrathin sectioning was per-
formed using a Diatome diamond knife on a Leica Ultracut UCT 
(Leica Biosystems Inc, UK), producing sections of 80–90nm thick-
ness, which were then collected on 2×1mm copper grids coated 
with pioloform film. The sections were counterstained at room 
temperature with 4% aqueous uranyl acetate for 35 min, washed 
3×, immersed in Reynolds lead citrate, (pH 12), for 10 min in a 
CO2-free environment, and finally washed 3× before air-drying. 
The sections were observed on a transmission electron microscope 
JEM-1400 (Jeol, Japan) operated at an accelerating voltage of 
80 kV using a magnification of ×5000 to ×25000. In experiments 
with gold nanoparticles, silver enhancement (R-Gent SE-EM, 
Aurion, Netherlands) was carried out for 45 min at room tempera-
ture, according to the manufacturer’s protocol, before processing as 
described above.
Data analyses
Fluorescence intensity analysis was carried out using ImagePro 
software and the percentage of pixels exceeding a threshold pixel-
density was measured, with a threshold set at mean+2SD of back-
ground. Flow cytometry was carried out using FACSCalibur™ to 
analyse 104 cells on each determination, using CellQuest software 
(Becton Dickinson, UK), to give median fluorescence. The gain 
voltage was set so that 90% of control, stained cells had fluorescence 
values <10. Cells with fluorescence >10 were considered positive. 
Graphical representations and statistical analyses were done with 
Graphpad Prism software, v. 3.0 (Prism, USA). Data were analysed 
by Anova, followed (if P< 0.05) by either Dunnet’s multiple com-
parison test, a t-test or a paired t-test as appropriate.
Results
Phenotype of human astrocytes in 3D gels
The characteristics of astrocytes cultured in collagen gels (3D-
astrocytes) for 7 days were compared to the same cells cultured 
on flasks (2D-astrocytes). Cells grown on flasks had increased 
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in number approximately 7-fold over this period, equivalent to 
2.9 ± 0.08 cell divisions. In contrast, there was no significant 
increase in the numbers of cells present in the gels after 7 days in 
culture. The difference between 2D-astrocytes and 3D-astrocytes 
(P=0.0009, paired t-test, n=4) indicates that culture in the 3D gel 
environment inhibits astrocyte proliferation. Over the same time 
period, the percentage of TE7+ fibroblasts increased significantly 
from 2% to 5% in both 3D-cultures (P=0.0483, paired t-test, n=3) 
and 2D cultures (P=0.0428, paired t-test, n=3), indicating that 
fibroblasts can proliferate slowly in the gels.
Over this period the percentage of GFAP+ cells was unchanged in 
the 3D gels, while the percentage in monolayer cultures fell from 
39% to 20% (P=0.0309). The maintenance of GFAP expression 
in 3D cultures of human astrocytes contrasts with previous results 
with rat astrocytes, which down-regulate GFAP expression in 
gel cultures (East et al., 2009). While 90% of the 2D-astrocytes 
expressed S100β, only approximately half of them were GFAP+. 
GFAP is often used as a standard marker of astrocytes, but in this 
study S100β appeared to be more consistently expressed in human 
astrocytes under different growth conditions than GFAP.
Dataset 1. Raw data for the statements made in the Results 
‘Phenotype of human astrocytes in 3D gels’
http://dx.doi.org/10.5256/f1000research.7142.d106539
Percentage of TE7- and GFAP- positive cells in Human astrocyte 
2D and 3D cultures after 7 days (Sreekanthreddy et al., 2015a).
Astrocyte-endothelial co-cultures
In the next step, hCMEC/D3 cells were added to the surface of 
compressed or uncompressed gels containing astrocytes (Figure 1). 
Compression increased the density of astrocytes and also made the 
gels considerably more resilient for TEM processing. In order to 
estimate the volume occupied by the astrocytes in the gels, the total 
area of the astrocytes was measured as a percentage of the gel, by 
image analysis of strips across the width of the cultures. In uncom-
pressed gels (1–2mm thick) the astrocytes occupied <1% of the gel, 
and in compressed gels (40–60μm thick) they occupied 6–10% of 
the gel (Figure 1). Direct contact between astrocytes at the surface 
of the gel and endothelium could be seen in TEM (Supplementary 
Figure 1). However, since the astrocyte density was always <10% of 
the gel volume the contact area between astrocytes and endothelium 
was less than 10% of the endothelial monolayer and the perme-
ability of the co-cultures to a 70kDa dextran tracer was not signifi-
cantly different to monocultures of hCMEC/D3 cells on transwell 
inserts (P>0.05, t-test, n=3). The upper limit on astrocyte density 
in the 3D cultures was determined by gel contraction and higher 
densities of astrocytes could be tolerated in compressed gels, due 
to their greater rigidity. The model allows analysis of local contacts 
between the astrocytes and endothelium by fluorescence or electron 
microscopy, which is an advantage over conventional co-cultures 
where the endothelium and astrocytes are separated by a filter up to 
30μm thick, and direct contact has not been observed.
Cell phenotypes in co-culture
Another advantage of the gel-based 3D co-culture is that either cell 
type can be readily observed by microscopy: the transparency of the 
collagen matrix allows imaging of the endothelial monolayer and 
Figure 1. 3-dimensional brain endothelium/astrocyte co-culture. Electron micrograph of a transverse section (85nm) of a compressed 
collagen type-1 gel with a co-culture of 3D-astrocytes and hCMEC/D3 endothelial cells; astrocytes occupy 6–10% of the gel as measured by 
image area. Scale bar = 2μm.
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astrocytes at different depths in the gel, by conventional light or fluo-
rescence confocal microscopy. Immunofluorescence microscopy was 
therefore used to examine the expression of characteristic molecules 
on the endothelium or the astrocytes in the 3D co-cultures. To assess 
expression of tight junction molecules, endothelial cells were immu-
nostained with anti-ZO-1 and anti-CLDN5. Staining for ZO-1 was 
continuous around the edge of the cells (Figure 2, upper), whereas 
CLDN5 was irregular, as described previously (Weksler et al., 2005) 
in both 2D and 3D cultures. Immunofluorescence staining of the 
tight junctions on the endothelium indicated that the structural 
organisation of the junctions was similar to that seen in conven-
tional solo cultures of hCMEC/D3 cells, grown on collagen-coated 
tissue-culture flasks. Staining of the astrocytes for AQP4 (Figure 2, 
lower) produced a homogeneous surface staining, with apparently 
lower expression on astrocytes in 3D co-cultures.
Two previous studies indicated that contact with endothelium can 
affect expression and localisation of aquaporin-4 (AQP4) in astro-
cytes (Al Ahmad et al., 2011; Nicchia et al., 2004). To investigate 
whether co-culture with endothelium was indeed affecting AQP4, 
we compared expression in 2D-astrocytes, 3D-astrocyte cultures 
and co-cultures. Culture of astrocytes in 3D gels, by itself causes a 
reduction in AQP4 expression both by immunofluorescence in situ 
(by image analysis) and by flow cytometry (Figure 3). The expres-
sion was further reduced when the astrocytes were in co-culture 
with endothelium (Figure 3). Expression of the endothelin recep-
tor, type B (EDNRB) was also reduced by approximately 16%, on 
3D-astrocytes by comparison with 2D-astrocytes as measured by 
flow cytometry (paired t-test, P=0.028 n=3). However, there was 
no additional change when the 3D-astrocytes were in a co-culture 
with endothelium.
Dataset 2. Raw data for aquaporin-4 expression (Figure 3)
http://dx.doi.org/10.5256/f1000research.7142.d106541
 AQP4 levels tested through flow cytometry and in-situ gel imaging 
analysis with results from paired t-tests (Sreekanthreddy et al., 
2015b).
It has previously been shown that astrocyte-conditioned medium 
(ACM) can enhance barrier properties in brain endothelium 
(Siddharthan et al., 2007) and induce the multi-drug transporter, 
P-glycoprotein (Megard et al., 2002). We therefore examined 
whether the factors released from 3D-astrocytes were more or less 
effective in inducing barrier phenotype in endothelial cells than 
Figure 2. Expression of ZO-1 and AQP4 in 2D- and 3D-astrocyte cultures. Immunofluorescence staining  in situ for expression of ZO-1 
in hCMEC/D3 cells (top) and AQP4 in human primary astrocytes (bottom) in 3D gel co-cultures (left) compared with conventional 2D solo 
cultures on a hard surface (right). 2D and 3D cultures were prepared, cultured, stained and imaged under the same conditions.
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Figure 3. Modulation of astrocyte AQP4 in 3D barrier model. 
Expression of AQP4  in 2D-astrocytes, 3D-astrocytes or astrocytes 
in  3D  co-cultures  (Co.) measured  by  immunofluorescence  in situ 
and  image  analysis  (left),  or  by  isolation  of  the  cells  and  flow 
cytometry (right). Fluorescence is expressed relative to the median 
value in 2D-astrocytes. Data points are the mean (±SEM) of median 
fluorescence values. 3D-astrocytes expressed lower levels of AQP4 
than  2D-astrocytes  and  the  expression  of  3D-astrocytes  further 
decreased in co-cultures (* P<0.05, paired t-test, n=3).
those from 2D-astrocytes. hCMEC/D3 cells were cultured with 
50% conditioned medium from either 2D-astrocytes or 3D-astro-
cytes and the area of staining measured by image analysis. The 
ACM from both sources induced ZO-1 and CLDN5 expression in 
hCMEC/D3 cells to a similar degree (Figure 4), but neither had any 
effect on P-glycoprotein expression (Figure 4).
Dataset 3. Raw data for expression of ZO-1, CLDN5 and Pgp 
(Figure 4)
http://dx.doi.org/10.5256/f1000research.7142.d106543
 Raw data for ZO-1 expression: Z0-1 expression-Fig-4.xlsx; Raw 
data for CLDN5 expression: CLDN5 expression-Fig-4.xlsx; Raw 
data for Pgp-1 expression: Pgp-1 expression-Fig-4.xls. Files show 
expression levels with basic statistics (mean, stdev, SEM) and 
paired t-test results (Sreekanthreddy et al., 2015c).
Use of the model for nanoparticle transfer and leukocyte 
migration
To examine the use of the model for assessing nanoparticle transport, 
3D co-cultures were set up on transwell inserts on 24-well plates 
and overlaid with 8μg/ml of 4nm glucose-coated gold nanoparti-
cles (Gromnicova et al., 2013). At intervals of 1–22 hours the cul-
tures were fixed and examined for the localisation of nanoparticles 
by TEM following silver enhancement (Figure 5, Supplementary 
Figure 2). The micrographs showed that these nanoparticles were 
located in the endothelium, the gel matrix and at later time points 
in astrocytes, suggesting that they move across the endothelium, 
and then diffuse through the gel matrix and then enter astrocytes 
(this class of nanoparticle is known to be able to cross plasma 
Figure 4. Modulation of ZO-1 and CLDN5 in 3D barrier model. 
Expression of ZO-1, CLDN5 and P-glycoprotein (P-gp) on hCMEC/
D3 cells  cultured  in control medium  from endothelium  (-),  or  50% 
astrocyte-conditioned  medium  from  either  2D-  or  3D-astrocytes. 
The  values  obtained  by  fluorescence  microscopy  are  expressed 
relative  to  the  median  fluorescence  of  control-treated  cells  in 
3 independent experiments. Data points are the mean (±SEM) of the 
median fluorescence. ZO-1 and CLDN5 are induced by 2D-astrocyte 
conditioned medium (* P<0.05, paired t-test, n=3), but there was no 
significant difference between 2D-astrocytes and 3D-astrocytes.
Figure 5. Co-culture model used to assess nanoparticle 
transmigration. Electron micrograph of a 3D co-culture of human 
primary astrocytes and hCMEC/D3 cells after application of 8μg/ml 
glucose-coated  gold  nanoparticles  to  the  endothelial  surface. 
Nanoparticles (arrows) were detected both in the endothelium and 
the astrocytes. Scale bar = 500nm.
membranes directly (Verma et al., 2008)). The model allows quan-
titation of the numbers of nanoparticles in the endothelium and 
astrocytes by particle counting, and it allows study of subcellular 
localisation of the nanoparticles. The model has recently been used 
for this purpose (Gromnicova et al., 2013). It is also theoretically 
possible to quantitate cell-associated and matrix-associated gold 
nanoparticles (by mass spectrometry) following separation of the 
components of the co-culture by the 2-step collagenase method.
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One particular advantage of the present 3D gel co-culture is that 
it allows nanoparticles to be released from the entire basal mem-
brane of the endothelium. In contrast, if endothelium is cultured 
directly on top of transwell filters, nanoparticles become trapped 
between the basal plasma membrane and the filter, except where 
there are pores (Figure 6). Moreover some types of nanoparticle 
bind strongly to filters and for these nanoparticles transwells are 
not suitable for quantitation of transfer rates, because of the losses 
on the filter.
We also examined the model to determine whether it could be used 
to assess leukocyte migration across the endothelium and through 
the gel. Collagen hydrogel co-cultures were established in tran-
swell inserts and the endothelium and astrocytes were activated 
by treatment with 1–10ng/ml TNFα plus IFNγ, either in the upper 
or lower chambers. Earlier studies have established that these 
conditions induce appropriate adhesion molecules and chem-
okine synthesis by the endothelium (Subileau et al., 2009). The 
endothelium was then overlaid with 105 Jurkat cells labelled with 
CMFDA and incubated for 16–24h. At the end of the incubation 
the cultures were observed by fluorescence microscopy and TEM. 
Confocal microscopy identified fluorescent lymphocytes associ-
ated with the endothelial monolayer, and with smaller numbers 
up to 300μm deep in the gel (Supplementary Figure 3). Migration 
into the gel was only seen with uncompressed gels. The TEM pic-
tures demonstrated that the lymphocytes had migrated through the 
endothelium, exhibiting the classical appearance of emperipolesis 
(Figure 7). The micrographs indicated that the majority of the leu-
kocytes detected had accumulated below the basal plasma mem-
brane of the endothelium but had not migrated into the gel at 24h 
(Supplementary Figure 4). Accumulation of leukocytes below the 
plasma membrane of brain endothelium but within the glia limi-
tans (perivascular cuffing) is also a characteristic of leukocyte 
migration into the CNS in vivo.
Discussion
The 3D co-culture model was developed to assess interactions 
between human brain endothelium and astrocytes and for its poten-
tial to measure trans-endothelial migration of nanoparticles and 
leukocytes. The configuration of these cultures offers three poten-
tial advantages: firstly astrocytes can directly contact the endothe-
lium; secondly, compared to 2D hard surface cultures, the 3D soft 
collagen gel matrix provides a physiologically more realistic cell 
environment, as indicated by inhibition of astrocyte proliferation; 
thirdly, nanoparticles, cells or biological agents released from the 
basal plasma membrane of the endothelium can directly enter the 
gel and/or astrocytes.
The model also has great potential for investigating the pheno-
type of the two cell types in co-culture, by light and fluorescence 
microscopy due to the transparency of the matrix. Compressed gels 
are also readily processed for TEM. Moreover as both cell types 
can be recovered separately by collagenase digestion, they can be 
individually analysed by many other techniques.
Figure 6. Limitations of transwells for assessing nanoparticle 
transmigration. Electron micrograph of a section through hCMEC/D3 
cells growing on a transwell filter, 1 hr after application of insulin-coated 
4nm gold nanoparticles  to  the apical surface. The cells were fixed 
and nanoparticles visualised by silver enhancement. Nanoparticles 
(arrows) are trapped between the filter and basal membrane, except 
where there are pores (P) in the filter. Scale bar = 1μm.
Figure 7. Co-culture model used to measure leukocyte 
transmigration. Migration  of  Jurkat  cells  in  a  3D-astrocyte-
endothelial  co-culture.  a)  At  3h  Jurkat  cells  (J)  are  seen  above 
and below  the endothelial  cells  (E), with  some cellular processes 
interleaved in the endothelial monolayer. b) At 24h the Jurkat cells 
are  located  between  the  endothelium  and  the  collagen  gel.  The 
arrow indicates an intact inter-endothelial junction. Transendothelial 
migration occurs by emperipolesis. Scale bars = 1μm.
a
b
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The second major use of this model was intended to be in measuring 
the movement of nanoparticles, across brain endothelium and into 
astrocytes. Delivery of therapeutic transgenes to cells within the CNS 
holds great potential for treatment of CNS diseases (Manfredson & 
Mandel, 2010), but developing systems that deliver the transgene to 
the target cell within the CNS is a challenge. Nanoparticles have the 
capacity to act both as drug carriers and transporters of therapeu-
tic transgenes (Kanwar et al., 2012). However there is currently no 
convenient system for measuring trans-endothelial movement of the 
nanoparticles in vitro and localising them in target cells. This model 
is well suited for this purpose. Nanoparticles can be tracked and 
quantitated by TEM (or light microscopy for larger particles). We 
have now used this model to quantitate delivery of different classes 
of nanoparticle to astrocytes in the gels and determine the rate and 
route of transfer across the endothelium (Gromnicova et al., 2013). 
We also evaluated the model for leukocyte migration. In comparison 
with another recently-developed astrocyte/endothelial co-culture 
(Takeshita et al., 2014), specifically designed for measuring leuko-
cyte migration, our model lacks shear stress, and is less suited for 
quantitation of leukocyte traffic, but can be used for characterising 
the trans-migrating cells and identifying their routes of migration.
Another related model which includes rat brain endothelium 
(RBE4-line), rat primary astrocytes and primary pericytes, in a col-
lagen gel has been developed previously (Al Ahmad et al., 2011). 
In this case all cells were incorporated into the gel matrix as the 
model was designed to investigate angiogenesis, and tubulogenesis. 
In comparison, it is less well suited for the analysis of mechanisms 
of transcytosis.
Conclusions
This 3D co-culture system with quiescent astrocytes in a collagen 
hydrogel overlaid with a monolayer of brain endothelium can be 
used for examining astrocyte-endothelial interactions; the two cell 
types can directly contact each other, although the overall contact 
area is limited. The model can also be used for investigating leu-
kocyte migration across brain endothelium. It is particularly well 
suited for measuring the delivery of nanoparticles, transgenes and 
larger biological molecules to cells of the CNS, following trans-
fer across the endothelium, because these larger entities can move 
freely from the basal surface of the endothelium, through the gel 
matrix and into the target cells.
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Supplementary material
Supplementary Figures 1–4. 
Supplementary Figure 1: Electron micrograph of a 3D-astrocyte endothelial cell co-culture (uncompressed). Astrocytes constitute approx-
imately 1% of the gel volume and in some places are in direct contact with the basal plasma membrane of the hCMEC/D3 cells. Scale 
bar = 2mm. Supplementary Figure 2: Electron micrograph of hCMEC/D3 cell 8 hrs after application of glucose-coated 4nm gold nanopar-
ticles to the apical surface. The cells were fixed and nanoparticles visualised by silver enhancement. Nanoparticles are present in the cytosol 
and below the basal membrane (arrows). Scale bar = 500nm. Supplementary Figure 3: Confocal micrograph of CMFDA-labelled Jurkat 
cells migrating into a 3D uncompressed co-culture. The endothelium was stimulated with 1ng/ml TNFa and 1ng/ml IFNg at time 0. Jurkat 
cells were applied to the apical surface and allowed to migrate for 24h before fixation. Nuclei of the endothelial cells are labelled with DAPI. 
Some Jurkat cells are associated with the endothelial monolayer, while others have migrated up to 300mm into the gel. Scale bar = 200mm. 
Supplementary Figure 4: Electron micrograph of Jurkat cells (J) migrating into a 3D uncompressed co-culture. Migration into the gel 
occurs at a point where the endothelial monolayer (E) is incomplete. Some astrocytes (A) are also visible in this section. Scale bar = 1mm.
Click here to access the data. 
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 Christopher C.W. Hughes
Department of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA, USA
There is a tremendous demand for a reproducible and representative model of the human blood brain
barrier and many versions have been tried. This paper represents an interesting variation, especially in
the dispensing of transwells, which impose an unacceptable separation between the endothelial cells and
the astrocytes.
 
There are a few issues I would like to see addressed, either by experimentation or additional discussion:
 
Pericytes are also an important component of the microvasculature and their addition here would
likely strengthen the relevance of the model.
 
Given the importance of astrocytes in promoting development of the BBB it would be interesting to
know whether they modulate additional markers of the BBB, such as ABC transporters, other than
ZO-1 and Claudin 5 (both of which are only weakly induced).
 
The failure to induce pgp and the relatively high leakiness of the monolayer are  concerns as pgp
expression and a tight barrier are both key features of the BBB .in vivo
 
Was a non-binding antibody used for the negative control in IF experiments? If so, this should be
stated.
 
AQP4 is reduced in overall expression in 3D culture, but is it relocalized to the contact points
between the astrocytes and the EC. This could be checked by confocal microscopy.
 
In Fig. 6, the arrows are missing.
 
In Fig. 7, “J” and “E” are missing from the figures.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 No competing interests were disclosed.Competing Interests:
Author Response 11 Jan 2016
Page 11 of 13
F1000Research 2015, 4:1279 Last updated: 25 DEC 2016
F1000Research
1.  
Author Response 11 Jan 2016
, The Open University, UKDavid Male
1. We agree with the reviewer that incorporating pericytes will make the model more relevant.
Some previous studies ( ) have included the pericytes in 3D collagen gels. It wouldAl Ahmad, 2010
be closer to the in vivo conditions if we could grow a layer of pericytes between the endothelial
monolayer and 3D cultured astrocytes. However, this will increase the complexity of the model, so
to keep the model simple and suitable to study transcytosis, we decided to include only two cell
types - the brain endothelium which must be crossed by nanoparticles and one example of a target
cell, the astrocytes. 
2. ABC transporter B1 also known as P-gp-1 is expressed in hCMEC/D3 at similar levels to primary
brain endothelium and was found not to be regulated by either 2D cultured or 3D cultures
astrocytes. These results are presented in figure 4.
3.  Although it is highly desirable that modesl should simulate all aspects of the blood brainin vitro 
barrier , this has not been possible with any models produced to date. In this case we makein vivo
it clear where the model is less useful (tight barrier properties and permeability for small molecules)
but it is nevertheless useful for the functions indicated - nanoparticle transcytosis and targeting to
astrocytes and leukocyte transendothelial migration.
4.  Immunofluorescence : For mouse monoclonal antibodies, the corresponding isotype
immunoglobulin was used as control whereas for rabbit polyclonal antibodies only antibody diluent
was used as control. This has been consistently followed in this study because we found that
normal rabbit IgG produced a weak non-specific binding, increasing the image backgrounds.
5. We agree with the referee and as mentioned in the main text, the model allows analysis of local
contacts between the astrocytes and endothelium by fluorescence or electron microscopy, which
is an advantage over conventional co-cultures. However, since the astrocyte density was always
<10% of the gel volume the contact area between astrocytes and endothelium was less than 10%
of the endothelial monolayer, number of contacts were less. Within these limited observations, we
did not see  relocalization of the AQP4 to the contacting end feet of astrocyte.
6/7 Additional annotations made to figures. 
 No competing interests were disclosed.Competing Interests:
 16 December 2015Referee Report
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 Abraham J. Al Ahmad
Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, TX,
USA
The manuscript sounds technically good and the results were innovative. However, I have some
recommendation or comments that would make bring this study to its highest potential.
Figure 2: A Claudin-5 immunostaining would be appreciated, especially to observe how the
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Figure 2: A Claudin-5 immunostaining would be appreciated, especially to observe how the
presence of astrocytes may improve claudin-5 immunoreactivity in hCMEC/D3 cells. What
happens to adherent junctions such as VE-cadherin, beta-catenin or PECAM-1? Having such
immunocytochemistry data in addition would greatly help.
A GFAP staining would be appreciated.
 
Figure 4: I have some concerns about the absence of error bars in P-gp control group, although
CLDN5 and ZO1 control groups display one. Please keep it consistent.
 
Figure 7: A true negative control such as TE7 fibroblasts is needed.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 No competing interests were disclosed.Competing Interests:
Author Response 11 Jan 2016
, The Open University, UKDavid Male
1. We have previously shown that Claudin-5 immunostaining on hCMEC-D3 cells is more patchy
than ZO-1 staining (Weksler et al, 2005). This may partly account for the relatively low
trans-endothelial resistance of this cell line. Cnsequently claudin-5 staining was not done. Data in
figure 4 suggests that claudin-5 is induced by astrocytic factors  although there was no significant
difference between 2D and 3D  culture factors. PECAM was unchanged in solo-culture and
co-culture (data not presented) and VE-cadherin was not investigated. A GFAP stain has been
added to supplementary material.
2. In figure 4 Pgp was measured by flow cytometry with data adjusted to the untreated cells on
each experiment (=100%). For this reason there are no error bars on the untreated cells. For
complete understanding of how the data was normalized see dataset 4.
3. A negative control image has been added to the supplementary material. 
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